EFTA01381281.pdf

Form S-I Table of Contents CAPITALIZATION The following table sets forth our cash and cash equivalents and capitalization as of March 31, 2015, on: • an actual basis; and • an as adjusted basis to give effect to the following, as if each had occurred on March 31, 2015: (1) the -for- stock split that we intend to effectuate prior to the effectiveness of the registration statement of which this prospectus forms a part and (2) the issuance of shares of common stock to certain non-management employees in connection with this offering. You should read this table together with "Prospectus Summary—Summary Consolidate) Financial Data: "Selected Consolidated Financial Data," "Management's Discussion and Analysis of Financial Condition and Results of Operations." "Underwriting" and our audited consolidated financial statements and unaudited condensed consolidated financial statements and the related notes included elsewhere in this prospectus. As of (In thousands) March 31, 2015 Actual As Adjusted Cash and cash equivalents (I) $ 149.044 $ 149,044 Long-tenn debt (including current maturities) Revolving credit facility (2) Term loan facilities 390.067 390,067 Total long-term debt 390.067 390.067 Stockholders' deficit: Common stock, $0.01 par value; authorized 49,300,000 shares, issued and outstanding 46,606.613 shares, actual; authorized shares, issued and outstanding shares, as adjusted 466 Additional paid-in capital 59455 Accumulated deficit (116,891) Total stockholders' deficit (56,770) Total capitalization $ 482,341 $ (I) Does not reflect offering expenses, which we estimate to be approximately $ (2) Our revolving credit facility consists of a $40.0 million revolving credit facility maturing on August 8, 2017. As of March 31. 2015. there were no outstanding borrowings under our revolving credit facility. 41 httplAvvew.see.gov/Arehi vas/edger/data/ 609989/000119312515218883/d734898dsl.htm(7/20/2015 10:30:13 AM) CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0080128 CONFIDENTIAL SDNY GM_00228312 EFTA01381281